Advances in Cancer Drug Targets is an e-book series that brings together recent expert reviews published on the subject with a focus on strategies for synthesizing and isolating organic compounds and elucidating the structure and nature of DNA. The reference work serves to give readers a brief yet comprehensive glance at current theory and practice behind employing chemical compounds for tackling tumor suppression, DNA site specific drug targeting and the inhibition of enzymes involved in growth control pathways. The reviews presented in this series are written by experts in pharmaceutical sciences and molecular biology. These reviews have been carefully selected to present development of new approaches to anti-cancer therapy and anti-cancer drug development. This e-book volume will be of special interest to molecular biologists and pharmaceutical scientists.


Advances in Cancer Drug Targets: Volume 1

End User License Agreement (for non-institutional, personal use)

The PIK3CA Gene as a Mutated Target for Cancer Therapy

AKT signaling is activated by VEGF and ANGiopoietins

Heavy metals regulate VEGF and HIF-1α expression via AKT pathway

AKT is the common target inhibited by different natural PRODUCTS with potential chemoprevention effects

Therapeutic perspectives for targeting AKT and mTOR

Inhibitors of Cyclin Dependent Kinases: Useful Targets for Cancer Treatment (An Update)

C-FILP AND THE DEATH RECEPTOR APOPTOSIS PATHWAY

TRANSCRIPTION AND TRANSLATION REGULATION OF C-FILP

C-FILP VARIANTS AS TARGETS FOR CANCER THERAPY

Cellular FLICE-Like Inhibitory Protein (C-FILP ): A Key Anti-Apoptotic Factor and a Target for Cancer Therapy

PIN1: A UNIQUE CANCER TARGET ACTING ON NUMEROUS CANCER-DRIVING PATHWAYS

Pin1: A Promising Novel Diagnostic and Therapeutic Target that Acts on Numerous Cancer-Driving Pathways

INDUCTION OF ANTICANCER IMMUNE REACTIVITY: IMMUNOREGULATORY DENDRITIC CELLS ORCHESTRATE THE DEVELOPMENT OF ANTI-CANCER T CELL REACTIVITY

INDUCTION OF ANTI-CANCER T CELL REACTIVITY BY DENDRITIC CELL VACCINES

THE EFFECTOR PHASE OF ANTICANCER IMMUNITY

IMMUNOSUPPRESSIVE EFFECTS OF CHEMOTHERAPY

REGULATORY T CELLS, TH17 T CELLS AND MESENCHYMAL STROMAL/STEM CELLS - KEY REGULATORS OF ANTICANCER IMMUNE REACTIVITY

ALLOGENEIC STEM CELL TRANSPLANTATION - AN ESTABLISHED COMBINATION OF PROAPOPTOTIC CHEMOTHERAPY AND IMMUNOTHERAPY

Anticancer Immunotherapy in Combination with Proapoptotic Therapy - Possible Therapeutic Strategies for Enhancement of Anticancer Immune Reactivity in Autologous Immunocompetent Cells and After Allogeneic Stem Cell Transplantation

INTRACRINOLOGY OF ESTROGEN DEPENDENT HUMAN BREAST CARCINOMA

MELATONIN AS A SELECTIVE ESTROGEN ENZYME MODULATOR

Melatonin and Breast Cancer: Selective Estrogen Enzyme Modulator Actions

Peripheral neuropathy as a critical limiting factor in anticancer treatment

Cisplatin-induced PN as a paradigm of CIPN

VPA in CDDP-induced PN: two birds with one stone?

Other histone hyper-acetylating strategies: Acetyl-L-carnitine

Targeting Cancer and Neuropathy with Histone Deacetylase Inhibitors

Bentham Science Publishers

"Topics in Anti-Cancer Research covers important advances on both experimental (preclinical) and clinical cancer research in drug development.  The book series offers readers an insight into current and future therapeutic approaches for the prevention of different types of cancers, synthesizing new anti-cancer agents, new patented compounds, targets and agents for cancer therapy as well as recent molecular and gene therapy research.
 
The comprehensive range of themes covered in each volume will be beneficial to clinicians, immunologists, and R&D experts looking for new anti-cancer targets and patents for the treatment of neoplasms, as well as varied approaches for cancer therapy.
 
The topics covered in the seventh volume of this series include:
- The role of ncRNAs in human cancer and its related patents
- Taxol to nanotaxol: a journey towards enhanced drug delivery
- Advanced therapy in cancer: stimuli-responsive nanocarriers for on-demand drug delivery
- The regulation and the function of autophagy in the development and behavior of esophageal cancers
- Recent patents on smart nano-formulations for cancer therapy
- Potential inflammatory mechanisms underlying chemotherapy-induced peripheral neuropathy and skeletal muscle effects
- Recent advances in nutrigenomics: patent applications
 "


Topics in Anti-Cancer Research: Volume 7

Khurshid Zaman

Atta-ur-Rahman

"Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest and the most important advances in anti-cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. Each volume is devoted to the major advances in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The eighth volume of the series features chapters covering the following topics:
- T cells in gastrointestinal cancers
- The pharmacology of adjudin – a male contraceptive with anti-cancer properties
- Manipulating the tumor microenvironment
- Treatment of hepatocellular carcinoma
- Gold-based compounds as potential anti-cancer drug candidates
- Oral nanostructure drug delivery for anti-cancer treatment"


Frontiers in Anti-Cancer Drug Discovery: Volume 8

Dr. M. lqbal Choudhary 

"Herbal Medicine: Back to the Future compiles expert reviews on the application of herbal medicines (including Ayurveda, Chinese traditional medicines and alternative therapies) to treat different ailments. The book series demonstrates the use of sophisticated methods to understand traditional medicine, while providing readers a glimpse into the future of herbal medicine.
 
 
 
This volume presents reviews of plant based therapies useful for treating different infectious diseases. The list of topics includes some niche reviews in this area including a review of the neem plant, the historical use of herbs in infectious disease therapy in Russia, and natural remedies from garlic, among other topics., The topics included in this volume are:
 
- Improving anti-microbial activity of allicin and carvacrol through stabilized analogs and nanotechnology
 
- Plant phenolics as an alternative source of antimicrobial compounds
 
- Herbal medicine in Russia’s history: the use of herbal medicine for infectious diseases in Russia’s history
 
- Azadirachta indica (neem) in various infectious diseases
 
- Contribution of novel delivery systems in the development of phytotherapeutics
 
 
 
This volume is essential reading for all researchers in the field of natural product chemistry and pharmacology. Medical professionals involved in internal medicine who seek to improve their knowledge about herbal medicine and alternative therapies for tropical and other infectious diseases will also benefit from the contents of the volume."


Infectious Diseases

Ferid Murad

Ka Bian

Frontiers in Clinical Drug Research – Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research. The sixth volume of this series features 6 reviews which are informative guides to therapy and drug administration in diabetes and metabolic syndrome, for both the medical specialist and the pharmacologist. - The failing heart in diabetes with special emphasis on prevention- Flavonoids as prominent anti-diabetic agents- Chemosensor in glucose monitoring, advances and challenges - Synergistic drugs and polyherbal formulations for obesity: current status and future prospectives- Urge for herbal anti-diabetic medicines towards clinical and therapeutic implications- Curcuma longa as a dietary supplement and medication for diabetes mellitus: evidence from experimental studies


Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 6

Frontiers in Anti-Cancer Drug Discovery” is an Ebook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.


Frontiers in Anti-Cancer Drug Discovery: Volume 2

"Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.
 
The fifth volume of the book features reviews on biochemical inhibitors (second-generation protein kinase Inhibitors, histone deacetylase inhibitors, immune checkpoint inhibitors, EGFR Tyrosine Kinase inhibitors, non-coding RNAs), apoptosis, and physical exercise therapy for cancer patients undergoing chemotherapy. The treatment strategies in this volume cover cancers such as acute myeloid leukemia, gastrointestinal cancer, breast cancer and lung cancer."


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5

"Frontiers in Anti-Cancer Drug Discovery” is an Ebook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The fifth volume of the series features chapters on the following topics:
-Nutraceuticals and natural food products for cancer treatment
-Pharmacogenomics in Anti-cancer treatment
-Cancer stem cells
-Potassium channel targeting for brain tumor treatment
-Sorafenib in the management of hepatocellular carcinoma
…and more.
 "


Frontiers in Anti-Cancer Drug Discovery: Volume 5

"Stem cell and regenerative medicine research is a hot area of research which promises to change the face of medicine as it will be practiced in the years to come. Challenges in the 21st century to combat diseases such as cancer, Alzheimer and related diseases may well be addressed employing stem cell therapies and tissue regeneration. Frontiers in Stem Cell and Regenerative Medicine Research is essential reading for researchers seeking updates in stem cell therapeutics and regenerative medicine. 
This volume includes reviews on the following topics: 
-the role of microvesicles and exosomes in mesenchymal stem cell (MSCs) in treating diseases while overcoming side effects
-alternative models for understanding cancer stem cell biology
-stem cells treatments for orthopaedic injury and endocrine disorders
-wound healing biomaterials
-theoretical models of hematopoietic cell dynamics (with implications for bone marrow transplants)"


Frontiers in Stem Cell and Regenerative Medicine Research: Volume 8

Shazia Anjum

"Advances in Organic Synthesis is a book series devoted to the latest advances in synthetic approaches towards challenging structures. The series presents comprehensive reviews written by eminent authorities on different synthetic approaches to selected target molecules and new methods developed to achieve specific synthetic transformations or optimal product yields. Advances in Organic Synthesis is essential for all organic chemists in academia and the industry who wish to keep abreast of rapid and important developments in the field.
 
This volume presents the following reviews:
Asymmetric hydrogenation of tetrasubstituted olefins
Recent advances in catalytic organic synthesis applications of covalently supported ionic liquids
Recent developments in intramolecular cyclization reactions via carbon-heteroatom (c-x) bond formation
Efficient synthetic protocol and mechanistic study of quinazoline analogues and their biological importance
Synthesis of N,O,S-heterocycles by one-pot reactions of epoxides, aziridines and oxaziridines
 "


Advances in Organic Synthesis: Volume 10

"Frontiers in Natural Product Chemistry is a book series devoted to publishing monographs that highlight important advances in natural product chemistry. The series covers all aspects of research in the chemistry and biochemistry of naturally occurring compounds, including research on natural substances derived from plants, microbes and animals. Reviews of structure elucidation, biological activity, organic and experimental synthesis of natural products as well as developments of new methods are also included in the series.
 
Volume seven of the series brings seven reviews covering these topics:
 
- Plant-Derived Anticancer Compounds Used in Cancer Therapies
 
- Pradimicin and Benanomicin Antibiotics
 
- The Chemical Compositions of Bixa orellana and their Pharmacological Activities
 
- Overview of Phytochemistry and Pharmacology of Nilakanthi (Ajuga bracteosa Wall. ex Benth.)
 
- Tetracyclic benzocarbazoles and derivatives
 
- Chalcones as Antiinflammatory, Antidiabetic, and Antidepressant Agents
 
- Bioactive Steroids from Marine Organisms"


Votre panier

Advances in Cancer Drug Targets: Volume 1

$ 89.00

description_of_book

Informations supplémentaires

À propos des auteurs

Atta-ur-Rahman

Topics in Anti-Cancer Research: Volume 7

Frontiers in Anti-Cancer Drug Discovery: Volume 8

Infectious Diseases

Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 6

Frontiers in Anti-Cancer Drug Discovery: Volume 2

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5

Frontiers in Anti-Cancer Drug Discovery: Volume 5

Frontiers in Stem Cell and Regenerative Medicine Research: Volume 8

Advances in Organic Synthesis: Volume 10

Frontiers in Natural Product Chemistry: Volume 7

Atta-ur-Rahman